Tianjin Pharmaceutical Da Ren Tang Group's strong financials...

Tianjin Pharmaceutical Da Ren Tang Group's strong financials hint at potential for long-term value increase despite recent stock price drop. Analysts predict continued earnings expansion due to the company's high ROE, net income growth, and efficient reinvestment.